Ss Innovations International Inc Revenue Growth Rates (AVMR), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Ss Innovations International Inc  (AVMR)
 

AVMR's Revenue Growth by Quarter and Year

Ss Innovations International Inc's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

AVMR Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -
2nd Quarter June 13.94
1st Quarter March 11.10
FY 25.04





AVMR Revenue second quarter 2026 Y/Y Growth Comment
Ss Innovations International Inc reported Revenue improvement of 39.4% year on year in the second quarter 2026, to $ 13.94 millions, this is lower than Ss Innovations International Inc's recent average Revenue surge of 201.68%.

Looking into second quarter 2026 results within Medical Equipment & Supplies industry 36 other companies have achieved higher Revenue growth. While Ss Innovations International Inc' s Revenue rise of 39.4% ranks overall at the positon no. 576 in the second quarter 2026.


AVMR Revenue ( Y/Y Growth %) 2026
 2025 2024 2023
4th Quarter December - 76.48 % 270.78 % 313.21 %
3rd Quarter September - 192.26 % 132.28 % -
2nd Quarter June 39.4 % 174.73 % 883.78 % -
1st Quarter March 11 % 599.3 % - -
FY   - 168.26 % 295.06 % -

Financial Statements
Ss Innovations International Inc's second quarter 2026 Revenue $ 13.94 millions AVMR's Income Statement
Ss Innovations International Inc's second quarter 2025 Revenue $ 10.00 millions Quarterly AVMR's Income Statement


AVMR Revenue (Quarter on Quarter Growth %)

 2026
 2025 2024 2023
4th Quarter December - 11.69 % 84.97 % 15.87 %
3rd Quarter September - 28.3 % 20.6 % 410.81 %
2nd Quarter June 25.58 % 0 % 154.55 % -
1st Quarter March -22.54 % 23.15 % -34.7 % -
FY (Year on Year)   - 168.26 % 295.06 % -


Back to AVMR Growth rate Comparisons >> Back to AVMR Growth rate Comparisons >>


Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #37
Healthcare Sector #139
Overall #576

Revenue Y/Y Growth Statistics
High Average Low
882.89 % 201.68 % -100 %
(Mar 31 2025)   (Jun 30 2026)
Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #37
Healthcare Sector #139
Overall #576
Revenue Y/Y Growth Statistics
High Average Low
882.89 % 201.68 % -100 %
(Mar 31 2025)   (Jun 30 2026)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Ss Innovations International Inc's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
411.16 % 34.54 % -100 %
(Jun 30 2023)  


AVMR's II. Quarter Q/Q Revenue Comment
Ss Innovations International Inc achieved in the II. Quarter 2026 below company average Revenue jump of 25.58% quarter on quarter, to $ 13.94 millions.

II. Quarter 2026 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the 0% in the II. Quarter a year ago.

Within Medical Equipment & Supplies industry 23 other companies have achieved higher Revenue quarter on quarter growth. While Ss Innovations International Inc's Revenue growth quarter on quarter, overall rank is 416.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #24
Healthcare Sector #93
Overall #416
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #24
Healthcare Sector #93
Overall #416
Revenue Q/Q Growth Statistics
High Average Low
411.16 % 34.54 % -100 %
(Jun 30 2023)  


AVMR's II. Quarter Q/Q Revenue Comment
Ss Innovations International Inc achieved in the II. Quarter 2026 below company average Revenue jump of 25.58% quarter on quarter, to $ 13.94 millions.

II. Quarter 2026 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the 0% in the II. Quarter a year ago.

Within Medical Equipment & Supplies industry 23 other companies have achieved higher Revenue quarter on quarter growth. While Ss Innovations International Inc's Revenue growth quarter on quarter, overall rank is 416.


Ss Innovations International Inc's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)		 12 Months Ending
(Mar 31 2026)		 12 Months Ending
(Dec 31 2025)		 12 Months Ending
(Sep 30 2025)		 12 Months Ending
(Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 52.20 $ 48.26 $ 47.16 $ 40.95 $ 32.50
Y / Y Revenue Growth (TTM) 60.59 % 84.61 % 168.45 % 251.84 % 255.5 %
Year on Year Revenue Growth Overall Ranking # 70 # 80 # 37 # 66 # 0
Seqeuential Revenue Change (TTM) 8.16 % 2.33 % 15.17 % 25.98 % 24.34 %
Seq. Revenue Growth (TTM) Overall Ranking # 696 # 901 # 380 # 556 # 590


Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Jun 30 2026 period, Ss Innovations International Inc's cumulative twelve months Revenue were $ 52 millions, company would post below average annual Revenue growth of 24.34% year on year, if the fiscal year would end at Jun 30 2026.
A slow-down in the Ss Innovations International Inc's Revenue growth from the 11.1% growth in Mar 31 2026.

Within the Healthcare sector 22 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 70, from total ranking in previous quarter at 80.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 43
Healthcare Sector # 23
Overall # 70

Revenue TTM Y/Y Growth Statistics
High Average Low
344.93 %
 194.32 %
60.59 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 43
Sector # 147
S&P 500 # 696
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Jun 30 2026 period, Ss Innovations International Inc's cumulative twelve months Revenue were $ 52 millions, company would post below average annual Revenue growth of 60.59% year on year, if the fiscal year would end at Jun 30 2026.
A slow-down in the Ss Innovations International Inc's Revenue growth from the 11.1% growth in Mar 31 2026.

Within the Healthcare sector 22 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 70, from total ranking in previous quarter at 80.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 43
Healthcare Sector # 23
Overall # 70

Revenue TTM Y/Y Growth Statistics
High Average Low
344.93 %
194.32 %
60.59 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 43
Sector # 147
S&P 500 # 696




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
AVMR's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue jump for the quarter ending Jun 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2026
Hyperfine Inc 67.70%$ 67.698 millions
Alnylam Pharmaceuticals Inc 66.86%$ 66.856 millions
Emergent Biosolutions Inc 66.29%$ 66.288 millions
Vivos Therapeutics Inc 65.69%$ 65.691 millions
Iovance Biotherapeutics inc 65.65%$ 65.654 millions
Billiontoone Inc 64.40%$ 64.403 millions
Anteris Technologies Global Corp 63.27%$ 63.269 millions
Nexgel Inc 63.24%$ 63.242 millions
Carlsmed Inc 59.58%$ 59.575 millions
Sonoma Pharmaceuticals Inc 59.55%$ 59.552 millions
Arcutis Biotherapeutics Inc 59.33%$ 59.331 millions
Nephros Inc 58.55%$ 58.551 millions
Bioadaptives Inc 54.95%$ 54.955 millions
Zevra Therapeutics Inc 53.25%$ 53.251 millions
Beyond Air Inc 52.94%$ 52.941 millions
Caredx Inc 52.23%$ 52.226 millions
Bioxcel Therapeutics Inc 51.67%$ 51.667 millions
Glaukos Corp50.63%$ 50.628 millions
Heartflow Inc 49.80%$ 49.801 millions
Coya Therapeutics Inc 48.97%$ 48.974 millions
Travere Therapeutics Inc 48.17%$ 48.174 millions
Halozyme Therapeutics Inc 47.67%$ 47.673 millions
Eli Lilly And Company47.67%$ 47.670 millions
Rhythm Pharmaceuticals Inc 46.91%$ 46.911 millions
Axsome Therapeutics Inc 45.54%$ 45.543 millions
Guardant Health Inc 44.33%$ 44.332 millions
Omada Health Inc 43.27%$ 43.273 millions
Mannkind Corporation42.92%$ 42.922 millions
Butterfly Network Inc 42.47%$ 42.466 millions
Beta Bionics Inc 42.26%$ 42.261 millions


About Ss Innovations International Inc Revenue Growth Rates (AVMR), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Ss Innovations International Inc (CIK 1676163).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001213900-26-088721
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Ss Innovations International Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.